Please enable Javascript
Jeff P. Sharman, MD
Jeff P. Sharman, MD
Articles by Jeff P. Sharman, MD
Benefits of Pirtobrutinib Treatment in Patients With Chronic Lymphocytic Leukemia
Jeff P. Sharman, MD
Chronic Lymphocytic Leukemia
|
January 25, 2025
Jeff P. Sharman, MD, discusses pivotal findings from the phase III BRUIN CLL-321 trial.
View More
Exploring Novel Mechanisms in Chronic Lymphocytic Leukemia
Jeff P. Sharman, MD
Chronic Lymphocytic Leukemia
|
January 24, 2025
Jeff P. Sharman, MD, explores unmet needs, prognosis, and novel treatments like pirtobrutinib in CLL.
View More